Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0392 Transporter Info
Gene Name SLC51B
Transporter Name Organic solute transporter subunit beta
Gene ID
123264
UniProt ID
Q86UW2
Microbiota Influence of This DT (MBI)

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC51B expression in metabolic dysfunction-associated fatty liver disease condition [1]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter SLC51B.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC51B expression in the health condition [2]

Regulating Factor
Chenodeoxycholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

In Vitro Model

 Human hepatoblastoma cells (HepG2)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC51B.

       Microbe Influence 2

 Down regulating of SLC51B expression in conventional mice compared with germ-free mice [3]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Large intestine

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51B.
References
1 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
2 Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1124-30.
3 RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2017 Dec;45(12):1225-1238.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.